Theradiag
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
ALTER | PA
Overview
Corporate Details
- ISIN(s):
- FR00140069U4 (+1 more)
- LEI:
- 969500CDG241WHIFL611
- Country:
- France
- Address:
- 14 RUE AMBROISE CROIZAT, 77183 CROISSY-BEAUBOURG
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Theradiag is a company specializing in the development, manufacturing, and marketing of in-vitro diagnostics (IVD) and theranostics tests. With over 30 years of experience, the company is a leader in biotherapy monitoring, providing innovative solutions that help clinicians measure the efficacy of treatments and enhance patient management. Its core offerings include the LISA-TRACKER® range of kits, primarily focused on autoimmune diseases and oncology. Theradiag leverages its expertise to develop diagnostic tools for personalized medicine, expanding its portfolio to assist in monitoring biotherapies across various treatment areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-20 13:02 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 265.7 KB | ||
| 2023-12-15 18:00 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 304.7 KB | ||
| 2023-12-07 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 169.5 KB | ||
| 2023-10-11 17:45 |
Inside Information / News release on accounts, results
|
English | 300.2 KB | ||
| 2023-10-11 17:45 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 302.7 KB | ||
| 2023-09-29 18:00 |
Informations privilégiées / Autres communiqués
|
French | 328.5 KB | ||
| 2023-09-18 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 249.0 KB | ||
| 2023-09-18 07:30 |
Inside Information / News release on accounts, results
|
English | 270.0 KB | ||
| 2023-07-17 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 298.0 KB | ||
| 2023-07-17 07:30 |
Inside Information / News release on accounts, results
|
English | 286.1 KB | ||
| 2023-07-05 17:45 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 271.7 KB | ||
| 2023-07-04 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 175.2 KB | ||
| 2023-06-01 17:45 |
Informations privilégiées / Autres communiqués
|
French | 206.2 KB | ||
| 2023-05-09 17:45 |
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 174.7 KB | ||
| 2023-04-27 17:45 |
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 6.0 MB |
Automate Your Workflow. Get a real-time feed of all Theradiag filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theradiag
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theradiag via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
